Vendor source

Reviewed 21 Jul 2026

Completeness Strong (72%)

Metastasis Detection APP

Visiopharm

Visiopharm has developed an AI deep learning application that has been trained to detect metastases in H&E stained lymph nodes associated with breast and colorectal adenocarcinoma. This APP enables pathologists to not only detect areas of metastases in lymph nodes. It also measures and orders metastases based on relevant features for either breast or colorectal cancer metastasis (largest metastasis diameter or total area of metastasis).

Supported by 6 papers

Key features

Measurement of the largest metastasis

Metastasis detection in lymph nodes (H&E)

General Information

Product name

Metastasis Detection APP

Company

Modality

Histopathology

Main task

Detection, Quantification

Subspeciality

Multiple

Organ/Specimen source

Lymph nodes

Disease targeted

Breast Cancer, Colorectal Cancer

Specimen type

Resection(s)

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Regulation (IVDR)

Class:

Class C

Verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

All standard scanners

Scanner Models Certified for Use (CE-IVD)

All standard scanners

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

Whole slide image, H&E, 20x or 40x magnification

Input format

DICOM, MRXS, NDPI, SVS, TIFF

Output

Segmentation overlay, diameter (breast cancer) or area (colorectal cancer) of the largest metastasis respectively

Output format

Not specified

Integration

Integration via AI marketplace or distribution platform, Integration with IMS (Image Management System), Integration with LMS (Laboratory Management System), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid, Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

Patients with Breast Cancer or Colorectal Cancer

Viewer systems

Not specified

Market Presence

On market since

01.2020

AI Platforms

Paige, PathAI AISight, Proscia, Sectra Amplifier Store

Resellers

Agilent, Proscia

Countries present

EU, UK

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of analyses

Source: Vendor | First published: Jul 30, 2025 | Last updated: Jul 21, 2026

Metastasis Detection APP - Visiopharm